Khaitan, JSA, TT&A Act On Viatris’ Divestment From Biocon Biotechnology & Pharma July 20, 2026 Capital Markets – Equity
JSA, ThinkLaw Advised On Param Capital’s Acquisition Of Intron Lifesciences Biotechnology & Pharma November 13, 2025 Mergers & Acquisitions
